Journal of Research and Development
Open Access
ISSN: 2311-3278
+44-77-2385-9429
ISSN: 2311-3278
+44-77-2385-9429
Italy
Extended Abstract
Pharmaceutical Sciences 2018: Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo-Silvia Martina Ferrari- University of Pisa
Author(s): Silvia Martina Ferrari
Introduction
Lenvatinib is an oral, multi-targeted tyrosine kinase inhibitor of the vascular endothelial growth factor receptors 1–3, fibroblast growth factor receptors 1–4, PDGFRα, RET and v-kit Hardy-Zuckerman feline sarcoma viral .. View More»